Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Change in Accured Expenses (2020 - 2025)

Beauty Health (SKIN) has disclosed Change in Accured Expenses for 6 consecutive years, with $2.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Accured Expenses rose 419.51% to $2.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$11.4 million, a 75.03% increase, with the full-year FY2024 number at -$43.8 million, down 199.49% from a year prior.
  • Change in Accured Expenses was $2.6 million for Q3 2025 at Beauty Health, up from -$4.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $40.9 million in Q3 2023 to a low of -$20.8 million in Q1 2024.
  • A 5-year average of $786210.5 and a median of -$3.1 million in 2023 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: skyrocketed 657600.0% in 2021, then crashed 573.78% in 2024.
  • Beauty Health's Change in Accured Expenses stood at $9.2 million in 2021, then plummeted by 154.21% to -$5.0 million in 2022, then decreased by 23.18% to -$6.1 million in 2023, then soared by 30.11% to -$4.3 million in 2024, then surged by 160.91% to $2.6 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Change in Accured Expenses are $2.6 million (Q3 2025), -$4.0 million (Q2 2025), and -$5.7 million (Q1 2025).